Objective　To investigate the method and effect of krypton laser photocoagulation for neovascularization in retinal vein occlusion.　Methods　Tweenty eight eyes of 27 patients with retinal vein occlusion with neovascularization were photocoagulated by krypton-green and-red laser.The fundus changes were observed by fundus fluorescein angiography after photocoagulation.　Results　The neovascularization disappeared completely in 20 eyes and became smaller in 6 eyes,remained no-change in 2 eyes,and the visual acuity improved in 17 eyes (60.7%) after 6 monthes to 2.5 years of follow-up.　Conclusion　Krypton laser photocoagulation is obviously effective on regression of neovascularization and prevenion of vitreous hemorrhage in retinal vein occlusion.

Objective To investigate the method and effect of krypton laser photocoagulation for neovascularization in retinal vein occlusion. Methods Tweenty eight eyes of 27 patients with retinal vein occlusion with neovascularization were photocoagulated by krypton-green and-red laser.The fundus changes were observed by fundus fluorescein angiography after photocoagulation. Results The neovascularization disappeared completely in 20 eyes and became smaller in 6 eyes,remained no-change in 2 eyes,and the visual acuity improved in 17 eyes (60.7%) after 6 monthes to 2.5 years of follow-up. Conclusion Krypton laser photocoagulation is obviously effective on regression of neovascularization and prevenion of vitreous hemorrhage in retinal vein occlusion.

Objective To investigate the therapeutic effects of thrombolysis infusion via microcatheter on the treatment of central retinal artery occlusion(CRAO). Methods Urokinase (UK) was directly infused via ophthalmic artery (OA) by microcatheter (6 patients) or via intravenous (7 patients) to dissolve the thrombus. The patency of the artery was evaluated by fundus fluorescein angiography (FFA), and the effect of fibrinolytic activity on the systemic changes was observed by blood biochemical examination simultaneously. Results In 6 patients in the microcatheter group, 5 had completely and 1 had partly reopened OA on the morrow of UK infusion with the patency rate of 83.33%, while in 7 patients in vein group, 3 completely reopened, 2 partly reopened and 2 obstructed OA were found with the patency rate of 42.86%. The difference between the two groups was significant. No obvious change of index of blood coagulation system was found in catheter group, which had great disparity compared with the vein group. Conclusion Urokinase infusion via microcatheter in CRAO has better therapeutic impact and smaller effect on systemic action.